Flynn James E 13D and 13G filings for Eucrates Biomedical Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-30 11:39 am Purchase |
2020-10-27 | 13G | Eucrates Biomedical Acquisition Corp. EUCRU |
Flynn James E | 1,000,000 7.780% |
1,000,000 (New Position) |
Filing |